IP Library › Granted Patent US 11,647,737
Granted Patent B2
US 11,647,737 · App. 16/475,127 · Granted May 16, 2023

Genetically modified rabbit expressing an exogenous protein in milk

Inventors: Ruby Yanru Tsai (San Jose, CA); Jie Xu (Fairfax, VA); Yuqing Chen (Superior Township, MI); Jifeng Zhang (Ann Arbor, MI); Ling-Jie Kong (Union City, CA)
Assignees: ASC THERAPEUTICS INC.; THE REGENTS OF THE UNIVERSITY OF MICHIGAN
A01K67/0278C07K14/4732C12N9/22C12N15/11C12N15/907A01K2217/072A01K2227/107A01K2267/01C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,647,737
App. No.
16/475,127
Granted
May 16, 2023
Kind
B2
Abstract

Provided is a genetically modified non-human mammal that comprises an anchor DNA sequence inserted at an endogenous locus of a secretory milk protein gene, wherein the anchor DNA sequence comprises a site-specific recombinase recognition site. Also provided is a genetically modified non-human mammal that comprises a transgene inserted at an endogenous locus of a secretory milk protein gene, wherein the transgene encodes a secretory protein and is operably linked to the endogenous promoter of said secretory milk protein gene, and wherein the transgene is flanked by a pair of site-specific recombinase resulting sites. The genetically modified non-human mammals provided can be used for producing the secreted recombinant protein encoded by the transgene from the milk produced by the genetically modified non-human mammals.

Claims (29)

1. A method for making a genetically modified rabbit, the method comprising:

a) introducing into a rabbit embryo:

i) a Cas protein or a nucleic acid encoding the Cas protein,

ii) a single guide RNA (sgRNA) that targets the nucleic acid sequence of SEQ ID NO:1, and

(iii) a DNA comprising a first recombinase recognition site (RRS), such that the DNA is inserted into intron 1 of an endogenous β-Casein gene in the rabbit embryo;

b) transferring the rabbit embryo to a female rabbit; and

c) generating a genetically modified rabbit whose genome comprises the first RRS in exon 1 of the endogenous β-casein gene from the rabbit embryo obtained in step b).

2. The method of claim 1 , further comprising introducing a homology directed repair (HDR) enhancer into the rabbit embryo in step a).

3. The method of claim 2 , wherein the HDR enhancer is RS-1.

4. A method for making a transgenic rabbit that is capable of expressing an exogenous protein in its milk, the method comprising:

d) obtaining an embryo from the genetically modified rabbit generated in step c) of claim 1 ;

e) introducing:

(i) a construct comprising a nucleic acid sequence encoding an exogenous protein and a second RRS, and

(ii) a recombinase into the embryo obtained in step in step d);

f) transferring the embryo obtained in step e) to a female rabbit; and

g) allowing the embryo obtained in step f) to develop into a transgenic rabbit whose genome comprises the nucleic acid sequence encoding the exogenous protein operably linked to an endogenous β-casein promoter and capable of expressing the exogenous protein in milk.

5. The method of claim 4 , further comprising:

h) inducing lactation in the transgenic rabbit obtained in step e); and

i) collecting said exogenous protein from milk of the transgenic rabbit obtained in step h).

6. The method of claim 4 , wherein the nucleic acid sequence encoding the exogenous protein comprises at its 5′ end a nucleic acid sequence encoding a signal-peptide.

7. The method of claim of 4 , wherein the nucleic acid sequence encoding the exogenous protein comprises at its 3′ end a polyA sequence.

8. The method of claim of 4 , wherein the exogenous protein is selected from the group consisting of antigen binding proteins, antibodies, vaccines, fusion proteins, enzymes, co-enzymes, clotting factors, and lysosomal proteins.

9. The method of claim of 4 , wherein the exogenous protein is human factor VII (FVII) or peptide LL37.

10. The method of claim 1 , wherein the recombinase is selected from the group consisting of Cre, Flp, the lambda integrase, gamma-delta resolvase, Tn3 resolvase, Sin resolvase, Gin invertase, Hin invertase, Tn5044 resolvase, IS607 transposase, Bxb1, wBeta, BL3, phiR4, A118, TG1, MR11, phi370, SPBc, TP901-1, phiRV, FC1, K38, phiBT1 and phiC31.

11. The method of claim 1 , wherein:

the DNA further comprises a nucleic acid sequence encoding a reporter protein, flanked by the first RSS and a second RSS,

the genetically modified rabbit has a genome comprising the nucleic acid sequence encoding the reporter protein operably linked to an endogenous β-casein promoter, and

expresses the reporter protein in milk.

12. The method of claim 11 , wherein the first RRS is phiC31-attP and the second RRS is Bxb1-attP, or vice versa.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2020
From: APPLIED STEMCELL, INC.
To: ASC THERAPEUTICS INC.
Reel/Frame 053130/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2019
From: TSAI, RUBY YANRU; KONG, LING-JIE
To: APPLIED STEMCELL, INC.
Reel/Frame 050069/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2019
From: XU, JIE; CHEN, YUQING; ZHANG, JIFENG
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 050069/0410 →
Continuity (2)
Provisional Application 62439896 · Dec 29, 2016
Related Publication 20190335729A1 · Nov 7, 2019